Diffusion Weighted Magnetic Resonance Imaging of the Breast During Chemotherapy: Response Evaluation

Completed

• Conditions: Breast Cancer

• Registration Number: NCT01684735
• Lead Sponsor: Universitaire Ziekenhuizen KU Leuven

Brief Summary

Evaluation of the response to chemotherapy in breast cancer patients by the use of Diffusion-weighted magnetic resonance imaging of the breast before the start of chemotherapy, after one and 3 cycles of therapy and at the end of the therapy.

Detailed Description

Not available

Study Timeline

• Study Start: 2012-03
• Study First Submitted: 2012-05-14
• Status Verified: 2012-09
• Study First Submitted QC: 2012-09-12
• Study First Posted: 2012-09-13
• Primary Completion: 2014-12
• Study Completion: 2014-12
• Last Update Submitted: 2023-01-27
• Last Update Posted: 2023-01-31

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 45

Inclusion Criteria

• core biopsy with diagnosis of breast cancer
• start of neo-adjuvant chemotherapy

Exclusion Criteria

• magnetic resonance imaging incompatibility

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Response to chemotherapy	1 year	outcome is the results of pathology after chemotherapy and surgery. Data will be collected for a period of 1 year.

Trial Locations

Locations (1)

University Hospitals Leuven; 🇧🇪 Leuven, Belgium